References
- McCarty DJ, Kohn NN, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome.” Ann Intern Med 1962;56(May):711–37
- Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease, pseudogout, chondrocalcinosis. In: McCarty DJ, Koopman WJ, eds. Arthritis and allied conditions: a textbook of rheumatology. 12th ed. Philadelphia: Lea & Febiger, 1993:1835–55
- Tate G. Gout: clinical features. In: Schumacher HR, Klippel JH, Robinson DR, eds. Primer on the rheumatic diseases. 9th ed. Atlanta: Arthritis Foundation, 1988:198
- Levinson DJ, Becker MA. Clinical gout and the pathogenesis of hyperuricemia. In: McCarty, Koopman, eds,2 pp 1773–1805
- Vawter RL, Antonelli MA. Rational treatment of gout: stopping an attack and preventing recurrence. Postgrad Med 1992;91(2):115–27
- Terkeltaub RA. Pathogenesis and treatment of crystal induced inflammation. In: McCarty, Koopman, eds,2 pp 1819–33
- Moskowitz RW. Diseases associated with the deposition of calcium pyrophosphate or hydroxyapatite. In: Kelley WN, Harris ED Jr, Ruddy S, et al, eds. Textbook of rheumatology. 3d ed. Philadelphia: Saunders, 1989:1450–2, 1458
- Schumacher HR, Reginato A. Atlas of synovial fluid analysis and crystal identification. Philadelphia: Lea & Febiger, 1991:128–9
- Xu Y, Cruz T, Cheng PT, et al. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1991;18(1):66–71